Suzhou Motif Biotech Co., Ltd. is located in the Suzhou High-Tech Zone as an innovative bioscience firm dedicated to the research, development, and production of peptide-related products. Founded in 2021, Motif Biotech launched its research and manufacturing operations in March 2023.Driven by peptide technology, Motif Biotech is dedicated to leading the CRDMO industry by integrating peptide research, process development, and API production.With decades of expertise in peptide synthesis, Motif Biotech is capable of producing over 95% of the peptide drugs available on the market. This is driven through a comprehensive process, starting from peptide drug design and screening to modification and optimization.

Motif Biotech’s integrated CRDMO platform provides fully customizable services for peptide drugs, covering every stage from early drug discovery to preclinical research and clinical trial sample production. By using advanced solid-phase, liquid-phase, and hybrid synthesis techniques, the company produces bioactive peptides tailored for diverse applications and specifications.